News Articles


Prognostic impact of COX-2 in lung cancer

COX-2 stroma.png

In a study performed by scientists at Uppsala University, in collaboration with Gothenburg University and the Human Protein Atlas project, the expression of cyclooxygenase-2 (COX-2) was evaluated in patients with non-small cell lung cancer (NSCLC).

To clarify previous inconsistences concerning the prognostic impact of COX-2 expression in NSCLC, the association between COX-2 transcript levels (encoded by the gene PTGS2) and overall survival in nine publicly available gene expression microarray data sets were evaluated as well as the in situ protein expression of COX-2 in tumor and stromal cells in two independent NSCLC cohorts...Read more


Upcoming Events


XII EuPA Congress

June 16, 2018 - June 20, 2018

On Tuesday June 19, Jochen Schwenk will present "An update on the Human Plasma Proteome" at the XII EuPA Congress - Translating genomes into biological functions.